Clinical Trial

Tackling Resistance And HealthCare Economics Through CPE Screening

Study acronym: TRACE-CPE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical study is to learn if it is possible to reduce the spread of resistant bacteria called CPEs (Carbapenemase producing Enterobacterales) between patients admitted to hospital. CPEs can be carried in the gut of people without making them ill. Normally when patients come into hospital, they may undergo a swab test on their bottom to see if CPEs can be grown. This test can take up to 24 hours to produce a result. The investigators want to use a faster test which takes 2 hours to produce a result, and whether this can make a difference to CPE spread between person to person. The main questions it aims to answer are: 1. Why do people carry, transmit or get infected with CPE? 2. If a faster test was used to look for CPE, would this be better at reducing patient spread in hospital? 3. Is a faster test also more cost effective? Participants will: 1. Be tested by both the usual and faster test when they come into hospital by a swab on their bottom 2. Where they test positive for CPE they will be asked to answer some questions about their health
Trial Details
NCT Number NCT07663110
Lead Sponsor Imperial College London
Conditions Carbapenem-Resistant Enterobacteriaceae, Colonisation
Enrollment 16,000 participants
Start Date 2026-08-01
Primary Completion 2027-11-01 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-23